Grace Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Grace Capital’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$67K	–	204
2019 Q4	$67K	Hold	20,000	–	–	0.05%	155
2019 Q3	$61K	Hold	20,000	–	–	0.06%	129
2019 Q2	$48K	Buy	20,000 +9,300	+87%	+$27.8K	0.02%	176
2019 Q1	$83K	Sell	10,700 -29,300	-73%	-$110K	0.03%	189
2018 Q4	$144K	Hold	40,000	–	–	0.07%	175
2018 Q3	$228K	Buy	+40,000	New	+$229K	0.09%	152

Grace Capital's FOMX Position: Q1 2020 in Review

Grace Capital sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 20,000 shares — an estimated $67K sold.

Grace Capital first reported a position in FOMX in Q3 2018 and held it in 6 quarters. The position peaked at $228K in Q3 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Grace Capital reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Grace Capital sold 20,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $67K.
Grace Capital first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2018 and held it in 6 quarters.
Grace Capital's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $228K in Q3 2018.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Grace Capital's 13F filing for Q1 2020, filed 12 May 2020.